Advertisement

Dementia, Delirium, and Depression

  • Heather S. AndersonEmail author
Chapter

Abstract

Concern about an older adult’s cognitive function is common, so any clinician involved in the care of older adults needs to be familiar with conditions which can affect cognitive function. Dementia, delirium, and depression can all cause memory loss and confusion, and all three conditions have different presentations and treatments. This chapter reviews the etiology, clinical evaluation and treatment options for dementia, delirium and depression in geriatric patients, and the relationship of these conditions to urologic healthcare for older adults.

Keywords

Urinary Incontinence Mild Cognitive Impairment Dementia With Lewy Body Vascular Dementia Acetylcholinesterase Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res. 1975;12:189–98.PubMedCrossRefGoogle Scholar
  2. 2.
    Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The Mini-Cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Takao H, Hayashi N, Ohtomo K. A longitudinal study of brain volume changes in normal aging. Eur J Radiol. 2011;81(10):2801–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol. 2003;60:989–94.PubMedCrossRefGoogle Scholar
  5. 5.
    Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–88.PubMedCrossRefGoogle Scholar
  6. 6.
    Thies W, Bleiler L. 2011 Alzheimer’s disease facts and figures. Alzheimers Dement. 2011;7:208–44.PubMedCrossRefGoogle Scholar
  7. 7.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 1994.Google Scholar
  8. 8.
    Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256:184–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Swerdlow RH. Brain aging, Alzheimer’s disease, and mitochondria. Biochim Biophys Acta. 1812;2011:1630–9.Google Scholar
  11. 11.
    Swerdlow RH, Burns JM, Khan SM. The Alzheimer’s disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim Biophys Acta. 2013.Google Scholar
  12. 12.
    Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Burns JM, Cronk BB, Anderson HS, et al. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 2008;71:210–6.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.PubMedCrossRefGoogle Scholar
  15. 15.
    Kuchel GA, Moscufo N, Guttmann CR, et al. Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2009;64:902–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Black SE. Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management. J R Coll Physicians Edinb. 2011;41:49–56.PubMedCrossRefGoogle Scholar
  17. 17.
    Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.PubMedCrossRefGoogle Scholar
  18. 18.
    Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc. 1999;47:564–9.PubMedGoogle Scholar
  19. 19.
    Mollenhauer B, Forstl H, Deuschl G, Storch A, Oertel W, Trenkwalder C. Lewy body and Parkinsonian dementia: common, but often misdiagnosed conditions. Dtsch Arztebl Int. 2010;107:684–91.PubMedCentralPubMedGoogle Scholar
  20. 20.
    McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. 2005. pp. 1863–1872.Google Scholar
  21. 21.
    Emre M. Dementia associated with Parkinson’s disease. Lancet Neurol. 2003;2:229–37.PubMedCrossRefGoogle Scholar
  22. 22.
    Bostrom F, Jonsson L, Minthon L, Londos E. Patients with Lewy body dementia use more resources than those with Alzheimer’s disease. Int J Geriatr Psychiatry. 2007;22:713–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007;68:812–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Aarsland D, Ballard C, Walker Z, et al. Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2009;8:613–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Pasquier F, Delacourte A. Non-Alzheimer degenerative dementias. Curr Opin Neurol. 1998;11:417–27.PubMedCrossRefGoogle Scholar
  26. 26.
    The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994;57:416–8.CrossRefGoogle Scholar
  27. 27.
    Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–21.PubMedCrossRefGoogle Scholar
  28. 28.
    Wittenberg D, Possin KL, Rascovsky K, Rankin KP, Miller BL, Kramer JH. The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev. 2008;18:91–102.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.PubMedCrossRefGoogle Scholar
  30. 30.
    Mendez MF, Lauterbach EC, Sampson SM. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci. 2008;20:130–49.PubMedCrossRefGoogle Scholar
  31. 31.
    Cardarelli R, Kertesz A, Knebl JA. Frontotemporal dementia: a review for primary care physicians. Am Fam Physician. 2010;82:1372–7.PubMedGoogle Scholar
  32. 32.
    Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry. 2007;15:84–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Johnson RT. Prion diseases. Lancet Neurol. 2005;4:635–42.PubMedCrossRefGoogle Scholar
  34. 34.
    Brown P, Gibbs Jr CJ, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994;35:513–29.PubMedCrossRefGoogle Scholar
  35. 35.
    Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–79. I: Clinical features. J Neurol Neurosurg Psychiatry. 1984;47:134–40.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Johnson RT, Gibbs Jr CJ. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med. 1998;339:1994–2004.PubMedCrossRefGoogle Scholar
  37. 37.
    Bernoulli CC, Masters CL, Gajdusek DC, Gibbs Jr CJ, Harris JO. Early clinical features of Creutzfeldt-Jakob disease (subacute spongiform encephalopathy). In: Prusiner SB, Hadlow WJ, editors. Slow transmissible diseases of the nervous system. New York, NY: Academic; 1979. p. 229–41.Google Scholar
  38. 38.
    Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76:1711–9.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med. 1965;273:117–26.PubMedCrossRefGoogle Scholar
  40. 40.
    Petersen RC, Mokri B, Laws Jr ER. Surgical treatment of idiopathic hydrocephalus in elderly patients. Neurology. 1985;35:307–11.PubMedCrossRefGoogle Scholar
  41. 41.
    Brean A, Eide PK. Prevalence of probable idiopathic normal pressure hydrocephalus in a Norwegian population. Acta Neurol Scand. 2008;118:48–53.PubMedCrossRefGoogle Scholar
  42. 42.
    Tanaka N, Yamaguchi S, Ishikawa H, Ishii H, Meguro K. Prevalence of possible idiopathic normal-pressure hydrocephalus in Japan: the Osaki-Tajiri project. Neuroepidemiology. 2009;32:171–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Hiraoka K, Meguro K, Mori E. Prevalence of idiopathic normal-pressure hydrocephalus in the elderly population of a Japanese rural community. Neurol Med Chir (Tokyo). 2008;48:197–9. discussion 199-200.CrossRefGoogle Scholar
  44. 44.
    Marmarou A, Young HF, Aygok GA. Estimated incidence of normal pressure hydrocephalus and shunt outcome in patients residing in assisted-living and extended-care facilities. Neurosurg Focus. 2007;22:E1.Google Scholar
  45. 45.
    Akiguchi I, Ishii M, Watanabe Y, et al. Shunt-responsive Parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol. 2008;255:1392–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Klassen BT, Ahlskog JE. Normal pressure hydrocephalus: how often does the diagnosis hold water? Neurology. 2011;77:1119–25.PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Iverson DJ, Gronseth GS, Reger MA, Classen S, Dubinsky RM, Rizzo M. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:1316–24.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Young J, Inouye SK. Delirium in older people. BMJ. 2007;334:842–6.PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35:350–64.PubMedCrossRefGoogle Scholar
  50. 50.
    McCusker J, Cole M, Dendukuri N, Han L, Belzile E. The course of delirium in older medical inpatients: a prospective study. J Gen Intern Med. 2003;18:696–704.PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    Inouye SK. Delirium in older persons. N Engl J Med. 2006;354:1157–65.PubMedCrossRefGoogle Scholar
  52. 52.
    Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58:249–65.PubMedCrossRefGoogle Scholar
  54. 54.
    Seitz D, Purandare N, Conn D. Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. Int Psychogeriatr. 2010;22:1025–39.PubMedCrossRefGoogle Scholar
  55. 55.
    Palsson S, Skoog I. The epidemiology of affective disorders in the elderly: a review. Int Clin Psychopharmacol. 1997;12 Suppl 7:S3–13.PubMedCrossRefGoogle Scholar
  56. 56.
    Martin LM, Fleming KC, Evans JM. Recognition and management of anxiety and depression in elderly patients. Mayo Clin Proc. 1995;70:999–1006.PubMedCrossRefGoogle Scholar
  57. 57.
    Wang J, Williams J, Lavorato D, Schmitz N, Dewa C, Patten SB. The incidence of major depression in Canada: the National Population Health Survey. J Affect Disord. 2010;123:158–63.PubMedCrossRefGoogle Scholar
  58. 58.
    Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer’s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64:492–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Ng TP, Niti M, Zaw MH, Kua EH. Depressive symptoms and incident cognitive impairment in cognitively well-functioning older men and women. J Am Geriatr Soc. 2009;57:1058–63.PubMedCrossRefGoogle Scholar
  60. 60.
    Lopez OL, Jagust WJ, Dulberg C, et al. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: part 2. Arch Neurol. 2003;60:1394–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Waern M, Rubenowitz E, Wilhelmson K. Predictors of suicide in the old elderly. Gerontology. 2003;49:328–34.PubMedCrossRefGoogle Scholar
  62. 62.
    National Center for Injury Prevention and Control. United States suicide injury deaths and rates per 100,000. 1999–2002. http://www.cdc.gov/ncipc/wisqars/. Accessed 14 May 2008.
  63. 63.
    Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80:90–6.PubMedCrossRefGoogle Scholar
  64. 64.
    Pintarelli VL, Perchon LF, Lorenzetti F, Toniolo Neto J, Dambros M. Elderly men’s quality of life and lower urinary tract symptoms: an intricate relationship. Int Braz J Urol. 2011;37:758–65.PubMedCrossRefGoogle Scholar
  65. 65.
    Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Raison CL, Master VA. Nocturia associated with depressive symptoms. Urology. 2011;77:183–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Coyne KS, Kvasz M, Ireland AM, Milsom I, Kopp ZS, Chapple CR. Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol. 2012;61:88–95.PubMedCrossRefGoogle Scholar
  67. 67.
    Losada A, Marquez-Gonzalez M, Garcia-Ortiz L, Gomez-Marcos MA, Fernandez-Fernandez V, Rodriguez-Sanchez E. Loneliness and mental health in a representative sample of community-dwelling Spanish older adults. J Psychol. 2012;146:277–92.PubMedCrossRefGoogle Scholar
  68. 68.
    Zorn BH, Montgomery H, Pieper K, Gray M, Steers WD. Urinary incontinence and depression. J Urol. 1999;162:82–4.PubMedCrossRefGoogle Scholar
  69. 69.
    Segrin C, Badger TA, Figueredo AJ. Stage of disease progression moderates the association between social support and depression in prostate cancer survivors. J Psychosoc Oncol. 2011;29:552–60.PubMedCrossRefGoogle Scholar
  70. 70.
    Hedgepeth RC, Gilbert SM, He C, Lee CT, Wood Jr DP. Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology. 2010;76:671–5.PubMedCrossRefGoogle Scholar
  71. 71.
    Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med. 2012;9:1497–507.PubMedCrossRefGoogle Scholar
  72. 72.
    Sheikh J, Yesavage J. Geriatric depression scale (GDS): recent evidence and development of a shorter version. In: Clinical gerontology: a guide to assessment and intervention. New York, NY: The Hawthorne Press; 1986. p. 165–73.Google Scholar
  73. 73.
    Tew Jr JD, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry. 1999;156:1865–70.PubMedGoogle Scholar
  74. 74.
    Boyce RD, Hanlon JT, Karp JF, Kloke J, Saleh A, Handler SM. A review of the effectiveness of antidepressant medications for depressed nursing home residents. J Am Med Dir Assoc. 2011;13(4):326–31.PubMedCentralPubMedCrossRefGoogle Scholar
  75. 75.
    Cuijpers P, Dekker J, Hollon SD, Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry. 2009;70:1219–29.PubMedCrossRefGoogle Scholar
  76. 76.
    GRS. Geriatrics review syllabus: a core curriculum in geriatric medicine. 6th ed. New York, NY: The American Geriatrics Society; 2006.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of NeurologyUniversity of Kansas Medical CenterKansas CityUSA

Personalised recommendations